Cultivates potential in complex accounts through a progressive account strategy approach & for Buy & Bill launch products. Cultivates mutually beneficial relationships to change short term business model thinking in a changing healthcare landscape. - District Sales Trainer (2024)- Hospital Formulary Development (2024)- Field Force Efficiency - IAT (2021-2023)- Launch for Products with 2 indications in Buy& Bill for infusion. (2022, 2023)- Launch of first speciality oral small molecule biologic in Gastro market. ( 2024) - Working mother of the year finalist (2020)- Ranked in Top 10 / 49 (2014, 2015, 2017 & 2019)- Highest Volume growth in the Nation – 51% (2015)- District Sales Trainer (2017, 2018)· RM/DM attendance to facilitate launch of marketing initiatives (2016)· “The Art of Argument”, Challenger Sales & “STUCK Account” Regional presentations. (2016)

Developed innovative strategies to build and acquire relationships within cardiology and endocrinology including the launch of 2 cholestrol products.Ranked in Top 12 for 7 of 8 years with AbbottAll Star Rank # 7 out of 120, launch-June (2010)All Star winner ranked # 4 out of 67 in a new product launch year (2009) Placed 1st in Simcor and Trilipix new product launch leader boards (2008 & 2009) Awarded 2nd place in National video role play competition (2009)Selected as Regional sales liaison to work on national compliance committee (2010)Selected as core member of Cardiovascular Specialty brand marketing panel (2010)Selected to be clinical data presenter at National meeting (2008)Selected to attend national Specialty Advanced Business Analytics Training. (2008)

Business acumen to propel Omnicef and Azmacort market share to 134% of quota. All Star Rank # 10 out of 70, improved from 69th position (2006) Selected as a member of the regional advisory board and marketing brand panel (2007)Nominated and attended Specialty Leadership development summit (2006)

Exceeded all sales goals. Chosen as team co-ordinator and regional field trainer.All Star winner ranked # 6 out of 70, improving from starting position of 53rd (2005)Hospital Formulary wins Increased Omnicef Suspension market share from 115% to 126% of quota and Biaxin XL to 103%.

National health care county systems and hospital salesAll Star winner ranked # 1 in the Nation, improved from a starting ranking of 41st (2003) Increased Meridia market share growth by 34% and Protonix (Protium) market share growth by 37%Biaxin XL and Meridia Formulary wins at Cambridge Hospital and Hinchingbrook Hospital

Clinical diagnostic cardiology, respiratory and allergy assessments, post assessment patient and physician consultations Lead member of project development team to create hospital’s sleep apnoea laboratoryBasic life support trainer

Multi-disciplinary rehabilitation program prescription and deployment of comprehensive corporate health risk assessment and wellness program at 3 major corporationsCreated and executed rehabilitation centre business development and marketing initiatives.